Inizio

About Inizio

Inizio is a global health and life sciences commercialization company formed in 2022 through the merger of Ashfield and Huntsworth. The company unites decades of experience with modern capabilities to create impactful solutions across the entire commercialization journey, from discovery through post-launch. With a network of over 10,000 experts operating across 50 countries, Inizio supports the world's leading health and life sciences businesses by providing strategic insight, medical excellence, creative engagement, and real-world delivery to solve complex challenges and achieve meaningful outcomes for clients and patients.